Negative role of inducible PD‐1 on survival of activated dendritic cells

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Leukocyte Biology

• Publication date

  2014-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1189/jlb.0813443PMID 24319287
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells

  2013cited by this paper
• PD-1 blockade enhances T-cell migration to tumors by elevating IFN-γ inducible chemokines.

  2012cited by this paper
• Durable Cancer Regression Off-Treatment and Effective Reinduction Therapy with an Anti-PD-1 Antibody

  2012cited by this paper
• Tumor-Infiltrating Programmed Death Receptor-1+ Dendritic Cells Mediate Immune Suppression in Ovarian Cancer

  2011cited by this paper
• A therapeutic dendritic cell-based vaccine for HIV-1 infection.

  2011cited by this paper
• PD-L2 is expressed on activated human T cells and regulates their function.

  2011cited by this paper
• The role of the PD‐1 pathway in autoimmunity and peripheral tolerance

  2011cited by this paper
• Cutting Edge: CD40–CD40 Ligand Pathway Plays a Critical CD8-Intrinsic and -Extrinsic Role during Rescue of Exhausted CD8 T Cells

  2011cited by this paper
• The PD‐1 pathway in tolerance and autoimmunity

  2010cited by this paper
• Uptake of apoptotic DC converts immature DC into tolerogenic DC that induce differentiation of Foxp3+ Treg

  2010cited by this paper
• PD-1 on immature and PD-1 ligands on migratory human Langerhans cells regulate antigen-presenting cell activity.

  2010cited by this paper
• PD-1 on dendritic cells impedes innate immunity against bacterial infection.

  2009cited by this paper
• Programmed death-1 receptor negatively regulates LPS-mediated IL-12 production and differentiation of murine macrophage RAW264.7 cells.

  2009cited by this paper
• Apoptotic Dendritic Cells Induce Tolerance in Mice through Suppression of Dendritic Cell Maturation and Induction of Antigen-Specific Regulatory T Cells1

  2009cited by this paper
• Immunological synapse formation inhibits, via NF-κB and FOXO1, the apoptosis of dendritic cells

  2009cited by this paper
• Regulation of dendritic cell survival and cytokine production by osteoprotegerin

  2009cited by this paper
• PD-1 and its ligands in tolerance and immunity.

  2008cited by this paper
• Deficiency of Bim in dendritic cells contributes to overactivation of lymphocytes and autoimmunity.

  2007cited by this paper
• Elimination of antigen-presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity.

  2007cited by this paper
• Therapeutic dendritic cell vaccination of patients with renal cell carcinoma.

  2006cited by this paper
• TLR4 and Toll-IL-1 Receptor Domain-Containing Adapter-Inducing IFN-β, but Not MyD88, Regulate Escherichia coli-Induced Dendritic Cell Maturation and Apoptosis In Vivo1

  2005cited by this paper
• PD‐L2:PD‐1 involvement in T cell proliferation, cytokine production, and integrin‐mediated adhesion

  2005cited by this paper
• LPS induces CD40 gene expression through the activation of NF-kappaB and STAT-1alpha in macrophages and microglia.

  2005cited by this paper
• LPS induces CD40 gene expression through the activation of NF-κB and STAT-1α in macrophages and microglia

  2005cited by this paper
• Prophylactic and therapeutic vaccination with dendritic cells against hepatitis C virus infection

  2005cited by this paper
• Signal transduction by the lipopolysaccharide receptor, Toll‐like receptor‐4

  2004cited by this paper
• Dendritic Cells Charged with Apoptotic Tumor Cells Induce Long-Lived Protective CD4+ and CD8+ T Cell Immunity against B16 Melanoma 1

  2003cited by this paper
• MHC class II-mediated apoptosis in dendritic cells: a role for membrane-associated and mitochondrial signaling pathways.

  2003cited by this paper
• Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade

  2002cited by this paper
• PD‐1:PD‐L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL‐2

  2002cited by this paper
• Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion

  2002cited by this paper
• Repetitive Injections of Dendritic Cells Matured with Tumor Necrosis Factor α Induce Antigen-specific Protection of Mice from Autoimmunity

  2002cited by this paper
• Differential regulation of maturation and apoptosis of human monocyte-derived dendritic cells mediated by MHC class II.

  2002cited by this paper
• Perforin‐independent regulation of dendritic cell homeostasis by CD8+ T cells in vivo: implications for adaptive immunotherapy

  2001cited by this paper
• Antigen-Specific Inhibition of Effector T Cell Function in Humans after Injection of Immature Dendritic Cells

  2001cited by this paper
• Induction of Interleukin 10–Producing, Nonproliferating Cd4+ T Cells with Regulatory Properties by Repetitive Stimulation with Allogeneic Immature Human Dendritic Cells

  2000cited by this paper
• Expression of c-FLIP(L) and resistance to CD95-mediated apoptosis of monocyte-derived dendritic cells: inhibition by bisindolylmaleimide.

  2000cited by this paper
• CD8+ T Cell-Dependent Elimination of Dendritic Cells In Vivo Limits the Induction of Antitumor Immunity1

  2000cited by this paper
• CD8 T Cell-Dependent Elimination of Dendritic Cells In Vivo Limits the Induction of Antitumor Immunity

  2000cited by this paper
• A Discrete Subpopulation of Dendritic Cells Transports Apoptotic Intestinal Epithelial Cells to T Cell Areas of Mesenteric Lymph Nodes

  2000cited by this paper
• Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity.

  1999cited by this paper
• Dendritic cells undergo rapid apoptosis in vitro during antigen-specific interaction with CD4+ T cells.

  1999cited by this paper
• Antigen-specific T lymphocytes regulate lipopolysaccharide-induced apoptosis of dendritic cells in vivo.

  1998cited by this paper
• Dendritic Cells Induce Autoimmune Diabetes and Maintain Disease via De Novo Formation of Local Lymphoid Tissue

  1998cited by this paper
• High Levels of a Major Histocompatibility Complex II–Self Peptide Complex on Dendritic Cells from the T Cell Areas of Lymph Nodes

  1997cited by this paper
• TRANCE (Tumor Necrosis Factor [TNF]-related Activation-induced Cytokine), a New TNF Family Member Predominantly Expressed in T cells, Is a Dendritic Cell–specific Survival Factor

  1997cited by this paper
• Activation of mitogen‐activated protein kinases via CD40 is distinct from that stimulated by surface IgM on B cells

  1996cited by this paper
• Brief Definitive Report Dendritic Cell Survival and Maturation Are Regulated by Different Signaling Pathways

  year unknowncited by this paper
• EncephalomyelitisExperimental Autoimmune Protein by Dendritic Cells Leads to Presentation of the Self Antigen Myelin Basic

  year unknowncited by this paper

• LAG-3 in (auto)immunity and cancer - Emphasising its role in antigen presenting cells.

  2026cites this paper
• Cribriform Plate Microenvironment Assembles a Suppressive Myeloid Network during EAE-induced Neuroinflammation

  2026cites this paper
• Unlocking the mystery of the PD-1/PD-L1 axis: beyond the checkpoint hype

  2025cites this paper
• The role of coinhibitory receptor-expressing non-T cells in inflammation and immunity: unsung heroes or peripheral players?

  2025influential citation
• Molecular Determinants for Photodynamic Therapy Resistance and Improved Photosensitizer Delivery in Glioma

  2024cites this paper
• High-dimensional mapping of human CEACAM1 expression on immune cells and association with melanoma drug resistance

  2024cites this paper
• High Level of CD8+PD-1+ Cells in Patients with Chronic Myeloid Leukemia Who Experienced Loss of MMR after Imatinib Discontinuation

  2024cites this paper
• Apoptosis of Dendritic Cells and Autoimmune Disease.

  2024cites this paper
• Immunoadjuvant therapy in the regulation of cell death in sepsis: recent advances and future directions

  2024cites this paper
• Amelioration of experimental autoimmune encephalomyelitis by exogenous soluble PD-L1 is associated with restraining dendritic cell maturation and CCR7-mediated migration.

  2024cites this paper
• Addition of nivolumab tailored by expansion of CAR-T cells in patients with stable/progressive large B cell lymphoma at lymphodepletion - a phase 2, prospective interventional study.

  2024cites this paper
• Reprogramming of PD-1+ M2-like tumor-associated macrophages with anti–PD-L1 and lenalidomide in cutaneous T cell lymphoma

  2023cites this paper
• Secondary metabolites of mulberry leaves exert anti-lung cancer activity through regulating the PD-L1/PD-1 signaling pathway

  2023cites this paper
• Combination treatment of pembrolizumab with DC-CIK cell therapy for advanced hepatocellular carcinoma: A case report

  2023cites this paper
• Immune Interactions in Pembrolizumab (PD-1 Inhibitor) Cancer Therapy And Cardiovascular Complications.

  2023cites this paper
• Identification of a novel cord blood NK cell subpopulation expressing functional programmed death receptor-1

  2023cites this paper
• Immunomodulatory Properties of Immune Checkpoint Inhibitors—More than Boosting T-Cell Responses?

  2022cites this paper
• Enhanced anti-tumor immunity of vaccine combined with anti-PD-1 antibody in a murine bladder cancer model

  2022cites this paper
• PD-1 expression on mouse intratumoral NK cells and its effects on NK cell phenotype

  2022cites this paper
• Noncanonical PD-1/PD-L1 Axis in Relation to the Efficacy of Anti-PD Therapy

  2022cites this paper
• LAG-3xPD-L1 bispecific antibody potentiates antitumor responses of T cells through dendritic cell activation

  2022cites this paper
• Accumulation of dysfunctional tumor-infiltrating PD-1+ DCs links PD-1/PD-L1 blockade immunotherapeutic response in cervical cancer

  2022cites this paper
• Non-canonical PD-1 signaling in cancer and its potential implications in clinic

  2021cites this paper
• Rethinking immune checkpoint blockade: ‘Beyond the T cell’

  2021cites this paper
• PD-1 expression on NK cells can be related to cytokine stimulation and tissue residency

  2021cites this paper
• The depths of PD-1 function within the tumor microenvironment beyond CD8+ T cells.

  2021cites this paper
• Neuroinflammation creates an immune regulatory niche at the meningeal lymphatic vasculature near the cribriform plate

  2021cites this paper
• Exploring the Pathogenic Role and Therapeutic Implications of Interleukin 2 in Autoimmune Hepatitis

  2020cites this paper
• Quantitative and qualitative impairments in dendritic cell subsets of patients with ovarian or prostate cancer.

  2020cites this paper
• Comprehensive insights into the effects and regulatory mechanisms of immune cells expressing programmed death-1/programmed death ligand 1 in solid tumors

  2020cites this paper
• Therapeutic targets and signaling mechanisms of vitamin C activity against sepsis: a bioinformatics study

  2020cites this paper
• On the Other Side: Manipulating the Immune Checkpoint Landscape of Dendritic Cells to Enhance Cancer Immunotherapy

  2019cites this paper
• SA-49, a novel aloperine derivative, induces MITF-dependent lysosomal degradation of PD-L1

  2019cites this paper
• Exploring the role of programmed cell death protein 1 and its ligand 1 in eye diseases

  2019cites this paper
• Evaluation of a ConvitVax/anti-PD-1 combined immunotherapy for breast cancer treatment

  2019cites this paper
• Immune inhibitory proteins and their pathogenic and therapeutic implications in autoimmunity and autoimmune hepatitis

  2019cites this paper
• [Blocking programmed death-ligand 1 attenuates maturation inhibition of dendritic cells by co-cultured breast cancer cells].

  2018cites this paper
• Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer

  2018cites this paper
• Combination Strategies to Optimize Efficacy of Dendritic Cell-Based Immunotherapy

  2018cites this paper
• The roles of PD‐1/PD‐L1 and its signalling pathway in gastrointestinal tract cancers

  2018cites this paper
• Antigen-Presenting Cell-Intrinsic PD-1 Neutralizes PD-L1 in cis to Attenuate PD-1 Signaling in T Cells

  2018influential citation
• Immunotherapeutic interventions of Triple Negative Breast Cancer

  2018cites this paper
• NK Cells Restrain Spontaneous Antitumor CD8+ T Cell Priming through PD-1/PD-L1 Interactions with Dendritic Cells

  2016cites this paper
• Hepatitis B core antigen upregulates B7-H1 on dendritic cells by activating the AKT/ERK/P38 pathway: a possible mechanism of hepatitis B virus persistence

  2016cites this paper
• PD-1 expression on dendritic cells suppresses CD8+ T cell function and antitumor immunity

  2016cites this paper
• Notch pathway plays a novel and critical role in regulating responses of T and antigen-presenting cells in aGVHD

  2016cites this paper
• Insights into the Apoptotic Death of Immune Cells in Sepsis

  2015cites this paper
• Programmed cell death-1 is expressed in large retinal ganglion cells and is upregulated after optic nerve crush.

  2015influential citation
• Altered Gut Microbiota Composition in Rag1-deficient Mice Contributes to Modulating Homeostasis of Hematopoietic Stem and Progenitor Cells

  2015cites this paper
• Antitumor Mechanisms of Immune Checkpoints PD-L1/PD-1 Blockade in Cancer Treatment

  2014influential citation
• Etude des mécanismes régulateurs des cellules NK : rôle de la molécule PD-1 et de la prostaglandine E2 (PGE2)

  2014cites this paper
• Protective effects of Fc-fused PD-L1 on two different animal models of colitis

  2014cites this paper
• Digital Commons@Becker Digital

  year unknowncites this paper